saRNA Injection Targets Cardiac Injury - Top-Institutions - MDSpire

saRNA Injection Targets Cardiac Injury

Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction

  • March 17, 2026

  • 2 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Gene Therapy
    • RNA Therapeutics

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Cardiology
    • Molecular Medicine
    • RNA Therapeutics

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Gene Therapy
    • Regenerative Medicine

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Cardiology
    • Gene Therapy
    • RNA Therapeutics

Original Source(s)

saRNA Injection Targets Cardiac Injury

  • March 17, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential

Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study